# 2026-04299: Restek Seeks Approval to Import Rare Controlled Substances

2026-04299, Importer of Controlled Substances Application: Restek Corporation, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-03-04, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 3, 2026. Such persons may also file a written request for a hearing on the application on or before April 3, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04299
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04299
- Title: Importer of Controlled Substances Application: Restek Corporation
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 10629
- Published: 2026-03-04
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 3, 2026. Such persons may also file a written request for a hearing on the application on or before April 3, 2026.
- Comments close: 2026-04-03
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Restek Seeks Approval to Import Rare Controlled Substances

## Summary

Restek Corporation wants to become an official importer of some controlled substances, including Amineptine and Mesocarb. People and companies involved with these drugs can share their thoughts or ask for a hearing by April 3, 2026. This move could affect how these substances are brought into the U.S., but no direct costs are mentioned yet.

## Abstract

Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- Importer Registration to Import Listed Controlled Substances: benefit, low. On February 11, 2026, Restek Corporation applied to be registered as an importer of the listed basic classes of controlled substances (examples include Amineptine and Mesocarb, and many other Schedule I and II substances). The company says it plans to import these substances to manufacture exempted…
- Import Authorization Excludes Finished Dosage Forms: cost, low. The DEA states authorization for this registration will not extend to importing FDA-approved or non-approved finished dosage forms for commercial sale. Approval will be granted only when the registrant's business activity is consistent with 21 U.S.C. 952(a)(2).

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-04299 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/04/2026-04299/importer-of-controlled-substances-application-restek-corporation)
- [2026-04299 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-04/pdf/2026-04299.pdf)

## Related
- [Previous: 2026-04298, Extension of a Currently Approved Information Collection: Special Bond of Indem…](https://policyrisk.com/federal-register/2026-04298)
- [Next: 2026-04300, Agency Information Collection Activities; Proposed eCollection eComments Reques…](https://policyrisk.com/federal-register/2026-04300)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04299 (as of 2026-06-08).
